Erratum: Isotretinoin is not associated with inflammatory bowel disease: A population-based case-control study (American Journal of Gastroenterology (2009) DOI:10.1038/ajg.2009.417;Isotretinoin is not associated with inflammatory bowel disease: A population-based case-control study

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2774-2778

  Bernstein, Charles N ^a   Nugent, Zoann ^a   Longobardi, Teresa ^a   Blanchard, James F ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ISOTRETINOIN;

ACNE; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; CROHN DISEASE; DATA BASE; ENTERITIS; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION; ULCERATIVE COLITIS;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; DERMATOLOGIC AGENTS; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; ISOTRETINOIN; MALE; ODDS RATIO; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TIME FACTORS; YOUNG ADULT;

EID: 72049105577     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.526     Document Type: Erratum

References (31)

1. Bernstein CN, Shanahan F. Disorders of a modern lifestyle-reconciling the epidemiology of inflammatory bowel diseases. Gut 2008 ; 57 : 1185-91.
2. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 2004 ; 99 : 1175-90.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K et al. The prevalence and geographical distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007 ; 5 : 1424-9.
4. Bernstein CN, Blanchard JF, Rawsthorne P et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a populationbased study. Am J Epidemiol 1999 ; 149 : 916-24.
5. Loftus CG, Loftus EV Jr, Harmsen WS et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis 2007 ; 13 : 254-61.
6. Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther 2006 ; 19 : 272-9.
7. White GM. Recent findings in the epidemiology, classification and subtypes of acne vulgaris. J Am Acad Dermatol 1998 ; 39 : 534-7.
8. Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Invest Dermatol Symp Proc 2004 ; 9 : 126-30.
9. Thevarajah S, Balkrishnan R, Camacho FT et al. Trends in prescription of acne medication in the US: Shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat 2005 ; 16 : 224-8.
10. Charakida A, Mouser PE, Chu AC. Safety and side eff ects of the acne drug, oral isotretinoin. Expert Opin Drug Saf 2004 ; 3 : 119-29.
11. Magin P, Pond D, Smith W. Isotretinoin, depression and suicide: a review of the evidence. Br J General Pract 2005 ; 55 : 134-8.
12. Kellett SC, Gawkrodger DJ. A prospective study of the responsiveness of depression and suicidal ideation in acne patients to diff erent phases of isotretinoin therapy. Eur J Dermatol 2005 ; 15 : 484-8.
13. Chia CY, Lane W, Chibnall J et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol 2005 ; 141 : 557-60.
14. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2005 ; 24 : 92-102.
15. Cohen J, Adams S, Patten S. No Association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort. Can J Clin Pharmacol 2007 ; 14 : e227-33.
16. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004 ; 292 : 726-35.
17. Martin P, Manley PN, Depew WT et al. Isotretinoin-associated proctosigmoiditis . Gastroenterology 1987 ; 93 : 606-9.
18. Reniers DE, Howard JM. Isotretinoin-induced inflammatory bowel disease in an adolescent. Ann Pharmacother 2001 ; 35 : 1214-6.
19. Spada C, Riccioni ME, Marchese M et al. Isotretinoin-associated Panenteritis . J Clin Gastroenterol 2008 ; 42 : 923-5.
20. Passier JLM, Srivastava N, van Puijenbroek EP. Isotretinoin-induced inflammatory bowel disease. Neth J Med: 2006 ; 64 : 52-4.
21. Carla R, Guilherme M. Isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2007 ; 102 : 1330.
22. Godfrey KM, James MP. Treatment of severe acne with isotretinoin in patients with inflammatory bowel disease. Br J Dermatol 1990 ; 123 : 653-5.
23. Reddy D, Siegel CA, Sands BE et al. Possible association between isotretinoin and inflammatory bowel disease. Am J Gastroenterol 2006 ; 101 : 1569-73.
24. Roos LL, Mustard CA, Nicol JP. Registries and administrative data: organization and accuracy. Med Care 1993 ; 31 : 201-12.
25. Metge CJ, Blanchard JF, Peterson S et al. Use of pharmaceuticals by IBD patients: a population-based study. Am J Gastroenterol 2001 ; 96 : 3348-55.
26. Bernstein CN, Metge C, Blanchard JF et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer? Am J Gastroenterol 2003 ; 98 : 2784-8.
27. Bernstein CN, Blanchard JF, Leslie WD et al. The incidence of fractures among patients with IBD: a population-based study. Ann Intern Med 2000 ; 133 : 795-9.
28. Jeremy AH, Holland DB, Roberts SG et al. Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 2003 ; 121 : 20-7.
29. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in IBD: a population-based study. Gastroenterology 2005 ; 129 : 827-36.
30. Strahan JE, Raimer S. Isotretinoin and the controversy of psychiatric adverse eff ects. Int J Dermatol 2006 ; 45 : 789-99.
31. Singh S, Graff LA, Bernstein CN. Do NSAIDs, antibiotics, infections or stress trigger flares in IBD? Am J Gastroenterol 2009 ; 104 : 1298-313.